Literature DB >> 16061636

Human LATS1 is a mitotic exit network kinase.

John Bothos1, Robyn L Tuttle, Michelle Ottey, Francis C Luca, Thanos D Halazonetis.   

Abstract

The kinase LATS/WARTS is a tumor suppressor protein conserved in evolution, but its function at the molecular level is not well understood. We report here that human LATS1 interacts with MOB1A, a protein whose homologue in budding yeast associates with kinases involved in mitotic exit. This suggested that LATS1 may be a component of the previously uncharacterized mitotic exit network in higher eukaryotes. Indeed, moderate overexpression of human LATS1 in cells exposed to microtubule poisons facilitated mitotic exit, and this activity required MOB1A. Reciprocally, small interfering RNA-mediated suppression of LATS1 or MOB1A prolonged telophase, but had no effect on the length of the earlier phases of mitosis. A role of LATS1 in mitotic exit may explain its previously described abilities to induce G2 arrest and promote cytokinesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061636     DOI: 10.1158/0008-5472.CAN-05-0862

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

Review 1.  Interdependence of cell attachment and cell cycle signaling.

Authors:  Elena N Pugacheva; Fabrice Roegiers; Erica A Golemis
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

2.  Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.

Authors:  Shin Akakura; Peter Nochajski; Lingqiu Gao; Paula Sotomayor; Sei-ichi Matsui; Irwin H Gelman
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

3.  MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation.

Authors:  Maria Praskova; Fan Xia; Joseph Avruch
Journal:  Curr Biol       Date:  2008-03-11       Impact factor: 10.834

4.  Defining the protein-protein interaction network of the human hippo pathway.

Authors:  Wenqi Wang; Xu Li; Jun Huang; Lin Feng; Keithlee G Dolinta; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2013-10-14       Impact factor: 5.911

5.  The Arabidopsis thaliana Mob1A gene is required for organ growth and correct tissue patterning of the root tip.

Authors:  Francesco Pinosa; Maura Begheldo; Taras Pasternak; Monica Zermiani; Ivan A Paponov; Alexander Dovzhenko; Gianni Barcaccia; Benedetto Ruperti; Klaus Palme
Journal:  Ann Bot       Date:  2013-11-07       Impact factor: 4.357

6.  Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.

Authors:  Chu Zhu; Xinyan Ji; Haitao Zhang; Qi Zhou; Xiaolei Cao; Mei Tang; Yuan Si; Huan Yan; Li Li; Tingbo Liang; Xin-Hua Feng; Bin Zhao
Journal:  J Biol Chem       Date:  2017-11-28       Impact factor: 5.157

7.  Cdc15 integrates Tem1 GTPase-mediated spatial signals with Polo kinase-mediated temporal cues to activate mitotic exit.

Authors:  Jeremy M Rock; Angelika Amon
Journal:  Genes Dev       Date:  2011-09-15       Impact factor: 11.361

8.  Monopolar spindle-one-binder protein 2 regulates the activity of large tumor suppressor/yes-associated protein to inhibit the motility of SMMC-7721 hepatocellular carcinoma cells.

Authors:  Weicheng Zhang; Jingyuan Shen; Fengming Gu; Ying Zhang; Wenjuan Wu; Jiachun Weng; Yuexia Liao; Zijing Deng; Qing Yuan; Lu Zheng; Yu Zhang; Weigan Shen
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

9.  The NDR kinase DBF-2 is involved in regulation of mitosis, conidial development, and glycogen metabolism in Neurospora crassa.

Authors:  Efrat Dvash; Galia Kra-Oz; Carmit Ziv; Shmuel Carmeli; Oded Yarden
Journal:  Eukaryot Cell       Date:  2009-12-04

10.  Polo-like kinase-1 controls Aurora A destruction by activating APC/C-Cdh1.

Authors:  Renske van Leuken; Linda Clijsters; Wouter van Zon; Dan Lim; XueBiao Yao; Rob M F Wolthuis; Michael B Yaffe; René H Medema; Marcel A T M van Vugt
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.